Rj. Tesi et al., THE FREQUENCY OF REJECTION EPISODES AFTER COMBINED KIDNEY-PANCREAS TRANSPLANT - THE IMPACT ON GRAFT-SURVIVAL, Transplantation, 58(4), 1994, pp. 424-430
The recipients of combined kidney-pancreas transplants (SPK) are uniqu
e because they routinely receive two allografts from the same donor. I
n a previous study, we found that the long-term graft survival of the
two allografts was different, with better graft survival seen in the p
ancreas allograft. In an attempt to understand the reason for the diff
erent graft survival in the recipients of organs from the same donor,
we have reviewed the incidence and timing of rejection episodes in 160
consecutive technically successful whole-organ bladder-drained SPK pe
rformed at a single institution using a uniform immunosuppressive regi
men. Rejection episodes were common. A total of 53% of the recipients
had at least one episode of rejection in one of the organs. Multiple r
ejection episodes requiring hospitalization occurred in 23% of the rec
ipients. The kidney allograft had more frequent rejection episodes tha
n the pancreas allograft: 78 patients had 130 renal rejection episodes
while only 50 patients had 65 episodes of pancreas rejection. No reje
ction episodes occurred in 111 pancreas and 82 kidney grafts (P=0.0014
). Multiple rejection episodes were three times as common in the kidne
y grafts (20%) than in the pancreas grafts (6%; P=0.0001). The timing
of the first rejection episode was also different. The median time to
the first kidney rejection episode was 29 days compared with 39 days t
o the first pancreas rejection episode (P=0.0191). Graft survival in t
he organs was equal when stratified by the number of rejection episode
s (none, one, > one) per organ (P=0.9378). These data suggest that the
worse long-term kidney graft survival seen in SPE( recipients is due
to the greater risk of rejection (relative risk: 2.04; [95% conf. inte
rval: 1.29-3.23]) and a greater frequency of rejection episodes of rej
ection episodes in the kidney (0.81/ patient) compared with the pancre
as (0.41/patient). The implications for patient management and the pos
sible reasons for the different rates of rejection are discussed.